Lung Therapeutics, Inc. STTR Phase I Award, September 2018
A STTR Phase I contract was awarded to Lung Therapeutics, Inc. in September, 2018 for $224,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Lung Therapeutics, Inc. STTR Phase I Award, September 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
